These were chiefly prostate tumors treated by radiotherapy and short-term hormonal treatment, breast cancers which were estrogen-receptor positive and treated by breast conserving surgery and radiotherapy, and rectal cancers which received preoperative radiotherapy. Here, ESR1 is linked to prostate neoplasm.